120 related articles for article (PubMed ID: 22313411)
21. The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer.
Demir AN; Kara Z; Sulu C; Uysal S; Zulfaliyeva G; Atar OA; Valikhanova N; Ozturk T; Ozkaya HM; Damci T; Gonen MS
Hormones (Athens); 2023 Dec; 22(4):595-602. PubMed ID: 37603221
[TBL] [Abstract][Full Text] [Related]
22. Second Primary Malignancy After Radioiodine Therapy in Thyroid Cancer Patient: A Nationwide Study.
Hong CM; Son J; Hyun MK; Lee JW; Lee J
Nucl Med Mol Imaging; 2023 Dec; 57(6):275-286. PubMed ID: 37982105
[TBL] [Abstract][Full Text] [Related]
23. The effect of radioactive iodine treatment for differentiated thyroid cancer on male gonadal function: a meta-analysis.
Cai Y; Yang Y; Pang X; Li S
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37855387
[TBL] [Abstract][Full Text] [Related]
24. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.
Vallejo Casas JA; Sambo M; López López C; Durán-Poveda M; Rodríguez-Villanueva García J; Santos RJ; Llanos M; Navarro-González E; Aller J; Pubul V; Guadalix S; Crespo G; González C; Zafón C; Navarro M; Santamaría-Sandi J; Segura Á; Gajate P; Gómez-Balaguer M; Valdivia J; Puig-Domingo M; Galofré JC; Castelo B; Villanueva MJ; Argüelles I; Orcajo-Rincón L
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35900793
[TBL] [Abstract][Full Text] [Related]
25. Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.
Bharadwaj MS; Ballal S; Bal C
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38214553
[TBL] [Abstract][Full Text] [Related]
26. Response to Letter to the Editor from Zandee and Links: "Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for
Gomes-Lima CJ; Chittimoju S; Wehbeh L; Dia S; Pagadala P; Al-Jundi M; Jhawar S; Tefera E; Mete M; Klubo-Gwiezdzinska J; Van Nostrand D; Jonklaas J; Wartofsky L; Burman KD
J Endocr Soc; 2023 Jan; 7(3):bvad005. PubMed ID: 36777465
[No Abstract] [Full Text] [Related]
27. Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.
Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Mete M; Jonklaas J; Wartofsky L
Endocr Pract; 2013; 19(1):139-48. PubMed ID: 23186979
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: a meta-analysis.
Tu J; Wang S; Huo Z; Lin Y; Li X; Wang S
Radiother Oncol; 2014 Jan; 110(1):25-30. PubMed ID: 24485353
[TBL] [Abstract][Full Text] [Related]
29. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
Mallick U; Harmer C; Yap B; Wadsley J; Clarke S; Moss L; Nicol A; Clark PM; Farnell K; McCready R; Smellie J; Franklyn JA; John R; Nutting CM; Newbold K; Lemon C; Gerrard G; Abdel-Hamid A; Hardman J; Macias E; Roques T; Whitaker S; Vijayan R; Alvarez P; Beare S; Forsyth S; Kadalayil L; Hackshaw A
N Engl J Med; 2012 May; 366(18):1674-85. PubMed ID: 22551128
[TBL] [Abstract][Full Text] [Related]
30. Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.
Rani D; Kaisar S; Awasare S; Kamaldeep ; Abhyankar A; Basu S
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1767-80. PubMed ID: 24687139
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human TSH increases uptake and effective half-life of radioiodine in thyroid hormone secreting metastases of follicular thyroid cancer.
Schneider C; Dietlein M; Eschner W; Schmidt M; Kahraman D; Kobe C
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):160-3. PubMed ID: 22328109
[TBL] [Abstract][Full Text] [Related]
32. Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis.
Giovanella L; Garo ML; Campenní A; Petranović Ovčariček P; Görges R
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173976
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers.
Hofmann MC; Kunnimalaiyaan M; Wang JR; Busaidy NL; Sherman SI; Lai SY; Zafereo M; Cabanillas ME
Endocr Relat Cancer; 2022 Nov; 29(11):R173-R190. PubMed ID: 35975971
[TBL] [Abstract][Full Text] [Related]
34. Strategies for Radioiodine Treatment: What's New.
Sparano C; Moog S; Hadoux J; Dupuy C; Al Ghuzlan A; Breuskin I; Guerlain J; Hartl D; Baudin E; Lamartina L
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954463
[TBL] [Abstract][Full Text] [Related]
35. Radioactive Iodine Treatment for Thyroid Cancer Patients Increases the Risk of Long-Term Gastrointestinal Disorders: A Nationwide Population-Based Cohort Analysis.
Lee Y; Chung CH; Lin LF; Chiu CH; Chen YF; Chang CF; Cheng CY; Chien WC
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626110
[TBL] [Abstract][Full Text] [Related]
36. Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for
Gomes-Lima CJ; Chittimoju S; Wehbeh L; Dia S; Pagadala P; Al-Jundi M; Jhawar S; Tefera E; Mete M; Klubo-Gwiezdzinska J; Van Nostrand D; Jonklaas J; Wartofsky L; Burman KD
J Endocr Soc; 2022 May; 6(5):bvac032. PubMed ID: 35356009
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal.
Tsai HC; Ho KC; Chen SH; Tseng JR; Yang LY; Lin KJ; Cheng JC; Liou MJ
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054388
[TBL] [Abstract][Full Text] [Related]
38. Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts.
Campennì A; Barbaro D; Guzzo M; Capoccetti F; Giovanella L
Endocrine; 2020 Nov; 70(2):280-291. PubMed ID: 32772339
[TBL] [Abstract][Full Text] [Related]
39. Failure of iodine uptake in microscopic pulmonary metastases after recombinant human thyroid-stimulating hormone stimulation.
Lawhn-Heath C; Flavell RR; Chuang EY; Liu C
World J Nucl Med; 2020; 19(1):61-64. PubMed ID: 32190026
[TBL] [Abstract][Full Text] [Related]
40. The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy.
Luo H; Tobey A; Auh S; Cochran C; Zemskova M; Reynolds J; Lima C; Burman K; Wartofsky L; Skarulis M; Kebebew E; Klubo-Gwiezdzinska J
Clin Endocrinol (Oxf); 2018 Oct; 89(4):481-488. PubMed ID: 29972703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
